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Abstract A rye flour protein of about 13.5 kDa, as well as its 
barley homologue, have been isolated. The rye component was 
recognized in vitro by IgE of allergic patients and provoked 
positive responses in 15 out of 21 baker's asthma patients (71%) 
when skin prick tests were performed. Its barley homologue 
showed no detectable in vitro reactivity and caused positive re- 
sponses in only one-third of patients. Although no inhibitory activ- 
ity against different a-amylases or trypsin was found for these 
two proteins, their N-terminal sequencing revealed considerable 
similarity to several members of the cereal ~x-amylase/trypsin 
inhibitor family. 
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1. Introduction 
Baker's asthma is a type I IgE-mediated allergic response to 
the inhalation of cereal flours, and represents an important 
occupational disease with elevated prevalence among workers 
of the cereal industry [1 3]. Although a number of allergens, 
including some additives [4], have been involved in baker's 
asthma, the salt-soluble proteins of flour dust seem to be the 
most relevant ones [5-7]. 
The best characterized wheat and barley flour allergens are 
12-16 kDa proteins that belong to the cereal a-amylase/trypsin 
inhibitor family [8-10]. Most members of this family show IgE 
binding capacity in vitro and cause positive responses in skin 
prick tests. However, very different allergenic activities have 
been found within this family, with the glycosylated compo- 
nents being the most reactive allergens [9,10]. In rice, members 
of the c~-amylase/trypsin inhibitor family are major allergens as 
well [11,12]. 
Cross-allergenicity among wheat, barley and rye flour has 
been reported [13,14]. In rye, two electrophoretic bands of 35 
kDa and 14 kDa have been shown to include major allergens 
by using sera of patients ensitized to wheat [14]. However, no 
allergenic proteins have been purified from rye flour as yet. We 
report here the identification of a new member of the c~-amy- 
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Abbreviations: BMA1, barley monomeric ~-amylase inhibitor; BTAI, 
barley tetrameric ~-amylase inhibitor; BTI, barley trypsin inhibitor; 
PVDF, poly (vinylidene difluoride); RAP, rice allergenic protein; 
RAST, radioallergosorbent test; SGE, starch-gel lectrophoresis; TFA, 
trifluoroacetic acid. 
lase/trypsin inhibitor family as a prominent rye allergen associ- 
ated with baker's asthma disease. 
2. Materials and methods 
2.1. Plant material 
Proteins were purified from rye (Secale cereale INIA C/171M) and 
barley (Hordeum vulgare cv. Bomi) flour. Disomic and ditelosomic 
rye wheat (S. cereale cv. Imperial x T. aestivum cv. Chinese Spring) and 
barley wheat (H. vulgare cv. Bomi x Z aestivum cv. Chinese Spring) 
addition lines were kindly provided by S.M. Reader (PBI, Cambridge, 
UK) and K.W. Shepherd (University of Adelaide, Australia), respec- 
tively. 
2.2. Pur~cation and characterization of proteins 
Salt-soluble protein preparations (0.15 M NaCI extraction and 
(NHa)2SO4 precipitation) enriched in inhibitors and their fractionation 
by gel-filtration on Sephadex G-100 under non-dissociating conditions 
were performed as previously described [15,16]. Fractions correspond- 
ing to dimeric inhibitors (Mr 25,000) were subjected to RP-HPLC. Sec 
c 1 was isolated on a Vydac-C4 column (22 x 250 mm, particle size 10 
¢tm) eluted by a three-step linear gradient of 1~50% acetonitrile in 
0.1% TFA (10-20% in 45 min, 20 35% in 140 rain, 35-50% in 100 rain; 
2 ml/min). BDP was obtained using similar RP-HPLC conditions, ex- 
cept that elution was by a linear gradient of 28~,8% (275 min; 1.5 
ml/min). The rye c~-amylase inhibitors were purified as in [16] and [17], 
and BMAI-I as in [18]. 
Protein concentration was quantified by the bicinchoninic acid assay 
[19]. SDS-PAGE was performed according to Laemmli [20], and two- 
dimensional electrophoresis a  in Gomez et al. [15]. Two-dimensional 
gels were stained with 0.05% (w/v) nigrosine in methanol:acetic 
acid:H20 (5:1:5, v/v/v) for 16 h. N-Terminal amino acid 
sequences were determined by standard methods using an Applied 
Biosystem 477A gas-phase sequenator. 
Inhibition tests of insect and human salivary c~-amylases were carried 
out as previously reported [16,21], and anti-trypsin activity was deter- 
mined according to Boisen and Djurtoft [22]. 
Glycoproteins were assayed after SDS-PAGE and electrotransfer to 
poly(vinylidene difluoride) membranes by a glycan detection kit (DIG; 
Boehringer) as in [9]. 
2.3. Chromosomal location of the gene Jor Sec c 1 
Individual kernels of ry~wheat addition lines were delipidated with 
petroleum ether and then extracted with 70% (v/v) ethanol as in [17]. 
These extracts were fractionated by two-dimensional electrophoresis 
(IEF, pH 5 8 x SGE, pH 3.2). 
2.4. Immunodetection 
Protein samples (1 yg) in TBS buffer (20 mM Tri-HC1, 150 mM 
NaC1, pH 8.3) containing 0.001% (w/v) SDS and 2% (v/v) 2-mercap- 
toethanol were heated (100°C, 5 min) and adsorbed to PVDF mem- 
branes. Alternatively, samples were subjected to SDS-PAGE and elec- 
trotransferred to PVDF membranes as in [9]. Immunodetection f 
IgE-binding proteins was performed with 1 : 3 dilutions of a pool ofsera 
from five baker's asthma patients (RAST class 4 to wheat and barley; 
Phadebas-RAST Kit, Pharmacia), and ~25I-labelled anti-human IgE, as 
reported in [23]. 
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2.5. In vivo diagnostic tests 
The in vivo allergenic activity of Sec c 1 and BDP was investigated 
by skin prick tests in 21 patients (RAST >-2 to rye) showing allergic 
sensitization torye flour. All patients exhibited positive responses when 
prick tests and inhalation challenge tests were carried out using com- 
mercial rye flour preparations (Leti, Spain). Informed consent was 
obtained in all cases. 
Protein samples were dissolved in 50% (v/v) glycerine, 0.9% (w/v) 
NaC1 at a final concentration f 100/lg/ml. 5¢tl of solution were applied 
in each case (2 repetitions per patient) using a DOME (Hollister-Stier) 
Bayer (1 mm T) lance (Morrow-Brown). After being transferred from 
the skin to adhesive paper, wheal areas were quantified by planimetry 
(HAFF planimeter 317). Taking into account he areas measured for 
atopic non-grain sensitive patients and healthy individuals, only wheals 
->7 mm 2 were considered as positive. Histamine (1%, w/v) and glycer- 
ine-NaC1 were used as positive and negative controls, respectively. 
3. Results 
3.1. Isolation oJ Sec c I and BDP 
A salt-soluble protein preparation was obtained from rye 
flour and fractionated by gel-filtration under non-dissociating 
conditions. Fractions with Mr 25,000, that include homo- 
dimeric proteins of the ~-amylase/trypsin inhibitor family (see 
[16]), were analyzed by two-dimensional electrophoresis (Fig. 
1A) and separated by RP-HPLC (Fig. 1B). One component 
with Mr 13,500 in SDS-PAGE (Fig. 1E), and showing a single 
spot on IEF x SGE (not shown), was purified using the above 
procedure. This protein was designated Secc 1 according to its 
allergenic properties ( ee below) and the new WHO/IUIS Aller- 
gen Nomenclature [24]. 
Following similar extraction and fractionation methods, a
polypeptide named BDP (barley dimeric protein) was purified 
from barley flour (Fig. 1C-E). 
Sec c 1 and BDP are related to the cereal ~-amylase/trypsin 
inhibitor family, but lack inhibitory activity 
The N-terminal amino acid sequences of Sec c 1 and BDP 
are closely related (70% identity in the first 20 amino acids; Fig. 
2). No heterogeneity was detected for any of the sequenced 
residues. Binary comparisons with members of the cereal ~- 
amylase/trypsin i hibitor family showed sequence identities 
ranging from 15% to 50%. The highest values (Fig. 2) were 
found for trypsin inhibitors BTI and RTI [25,26], as well as rye 
c~-amylase inhibitor-3 and its wheat (WTAI-CM2) and barley 
(BTAI-CMa) homologues [16]. Interestingly, major allergens 
from barley (BMAI [8,18]) and rice (RAP [11,12]) also showed 
significant sequence identity (>35%). 
The above homologies prompted us to investigate the inhib- 
itory activity of both purified proteins against ~-amylases from 
Tenebrio molitor (Coleoptera), Ephestia kuehniella (Lepidop- 
tera) and human saliva, as well as against bovine trypsin (en- 
zymes that are inhibited by different members of the cereal 
~-amylase inhibitor family from rye and barley [16,25]). Neither 
Sec c 1 nor BDP showed inhibitory activity against the enzymes 
tested. 
3.2. The genes for Sec c I and the rye o~-amylase inhibitor-3 are 
located in the same chromosome arm (4RL ) 
The chromosomal location of the gene for Sec c 1 was deter- 
mined by two-dimensional electrophoretic analysis of ethanol 
extracts from rye (cv. Imperial)-wheat (cv. Chinese Spring) 
addition lines (Fig. 3). Sec c 1 was present only in the addition 
lines 4R (disomic) and 4RL (ditelosomic). The same result was 
obtained for the rye ~-amylase inhibitor-3. The positions of 
both components in the protein map were ascertained by 
co-electrophoresis of the purified proteins and the Imperial 
extract. 
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Fig. 1. Two-dimensional electrophoretic (A,C) and RP-HPLC (B,D) separations ofthe M r 25,000 gel-filtration ( on-dissociating conditions) fractions 
of salt-soluble protein preparations from rye (A,B) and barley flour (C,D). Positions of Sec c 1 (A,B), BDP (C,D) and the major rye (RI; A) and 
barley (BI; C) homodimeric inhibitors are indicated. Fractions containing Sec c 1 and BDP were identified after HPLC by co-electrophoresis 
(IEF x SGE) with the corresponding gel-filtration fractions. E) SDS-PAGE of the following samples: salt-soluble protein preparations from rye (TR) 
and barley (TB) flour; gel-filtration fractions with M r ~25,000 from TR (FR) and TB (FB); purified Sec c 1 (Sec) and BDP (BD). 
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IDENTICAL RESIDUES 
Sec BDP BTI RAI BMAI RAP 
Secc  i EQCYGESCRVGKSISNNPVPACREYV 14/20 11/23 9/23 9/24 10/26 
BDP ERDYGEYCRVGKSIP INPLP  - 7/17 7/17 7/18 9/20 
BTI FGDSCAPGDALPHWPLRACRTYV 12/23 9/23 10/23 
RAI-3 TGPYCYP(~MGLPTKPLEGCREYV 11/23 10/23 
BMAI SPGEWCWPGMGYPVYPFPRCRALV - 15/24 
RAP DHHQVYSPGEQCRPGISYPTYSLPQCRTLV 
Fig. 2. Alignment of the N-terminal amino acid sequences of Sec c 1 and BDP with those of BTI (barley trypsin inhibitor [26]), RAI-3 (rye s-amylase 
inhibitor-3 [8,18]), and RAP (rice allergenic protein [12]). 
Likewise, barley (cv. Betzes) wheat (cv. Chinese Spring) ad- 
dition lines were analyzed to ascertain the chromosomal loca- 
tion of the gene for BDP. Although BDP was present in the 
two-dimensional map of Betzes, it could not be detected in any 
of the barley-wheat ddition lines, even when another electro- 
phoretic procedure (IEF, pH 5 11 × PAGE, pH 8.8) was used. 
3.3. Sec c 1 shows IgE b&ding capacity in vitro and allergenic 
activity in vivo 
The in vitro IgE binding capacity of Sec c 1 and BDP was 
tested by dot-blotting and immunodetection, using a pool of 
sera from baker's asthma patients (RAST class 4 to wheat) and 
'25I-labelled anti-human IgE (Fig. 4). Whereas Sec c 1 was able 
to bind specific IgE from allergic patients, BDP gave a negative 
response under the same experimental conditions. The presence 
of other major IgE binding components, beside Sec c 1, in the 
salt-soluble rye protein preparation can explain its stronger 
reaction with respect o Sec c 1. 
To compare the responses of Sec c 1 and other salt-soluble 
rye proteins, including members of the a-amylase inhibitor 
family (inhibitors 1-3 [16]; and the rye dimeric inhibitor RDI-l 
[17]), flour proteins were fractionated by SDS-PAGE, electro- 
transferred to PVDF membranes and probed as described 
above (Fig. 5). Two bands of M r 13,000 and 32,000 were the 
most reactive ones. Among the main components of the 13,000 
band, which include Sec c 1 and several proteins purified previ- 
ously [16], only Sec c 1 showed high IgE binding capacity. 
To investigate he allergenicity of Sec c 1 and BDP in vivo, 
skin prick tests were carried out in 21 patients allergic to cereal 
flour (RAST class 2-3 to rye). Sec c 1 provoked positive re- 
sponses (i.e. papules with areas ->7 mm 2) in 70% of the patients, 
while only one third of them reacted to BDP. Furthermore, the 
mean papule area (considering only positive results) was 2.7- 
times higher for Sec c 1 than for its barley homologue. 
Since the most reactive allergens of the cereal inhibitor family 
are glycoproteins, we investigated the presence of oligosac- 
charide-side chains bound to Sec c 1 or BDP. By using a glycan 
detection kit and the glycosylated allergen BMAI-1 from barley 
[18] as a positive control, we concluded that none of the two 
purified proteins is glycosylated (not shown). 
4. Discussion 
Two salt-soluble proteins, designated Sec c 1 (allergen o- 
menclature) and BDP (barley dimeric protein), have been iso- 
lated from rye and barley flour, respectively. Both components 
co-elute in gel-filtration with the major homodimeric inhibitors 
of insect a-amylases previously described in these two cereal 
species [17,27]; Fig. 1). Furthermore, they show apparent sizes 
in SDS-PAGE (M r - 13,500), isoelectricpoints (pI ~ 6), and solubil- 
ity properties imilar to those of dimeric inhibitors. However, 
neither Sec c 1 nor BDP inhibited trypsin or any of the c~- 
amylases tested. 
Sec c 1 and BDP have 70% identical N-terminal sequences, 
suggesting that they are equivalent components from rye and 
barley. Comparison of their amino acid sequences with those 
of different members of the cereal a-amylase/trypsin inhibitor 
family confirmed that Sec c 1 and BDP are homologous to this 
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Fig. 3. Two-dimensional protein maps (IEF pH 5 8 × SGE pH 3.2) of 70% ethanol extracts from individual grains of Secale cereale cv. Imperial 
(A), a mixture of S. cerale cv. Imperial and Tritieum aestivum cv. Chinese Spring (B), and Imperial-Chinese Spring ditelosomic addition line 4RL 
(C). Positions of Sec c 1 (S) and rye 0~-amylase inhibitor-3 (R) are indicated. 
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Fig. 4. IgE immunodetection by dot-blotting of the following samples: 
0.15 M NaCI extract precipitated with (NH4)2SO4 from barley (B) and 
rye (R) flour; purified Sec c 1 (S), BDP (BD), and the major barley 
allergen BMAI-I (BM; positive control). Samples (1/~g) were adsorbed 
to PVDF membranes and treated with a pool of sera from baker's 
asthma patients and t251-1abelled anti-human IgE. 
protein group (Fig. 2). Major allergens from barley and rice 
[8,11,12,18] also show significant sequence similarity to Sec c 
1 and BDP (up to 38% identical residues). 
Particularly interesting is the relationship between Sec c 1 
and the rye c~-amylase inhibitor-3 [16]. Both proteins have 39% 
identical residues in their N-termini and are encoded by genes 
located in the same chromosome arm (4RL; Fig. 3). The two 
components seem to be products of a gene duplication event 
that has resulted in two polypeptides with different inhibitory 
activities. Gene duplication appears to have played a major role 
in the evolution of the inhibitor multigene family [25]. However, 
Sec c 1 and rye ~-amylase inhibitor-3 represent the first case 
where both products do not show similar specificities towards 
the same hydrolytic enzyme. 
Together, our data indicate that Sec c 1 and BDP must be 
considered as new members of the cereal a-amylase/inhibitor 
family, in spite of their lack of inhibitory activity against he 
enzymes tested. In fact, changes within the N-terminal region 
like those shown by Sec c 1 and BDP with regard to other active 
members of the inhibitor family, have been reported to produce 
complete inactivation or to reduce drastically the inhibitory 
activity when variants of a wheat monomeric inhibitor are 
generated by site-directed mutagenesis [28]. 
The homology of Sec c 1 and BDP to different cereal aller- 
gens associated with baker's asthma led us to test their IgE 
binding capacity using a pool of sera from patients ensitized 
specifically to wheat flour. In the case of salt-soluble proteins 
from rye, two major reactive bands with Mrs 32,000 and 13,000 
were detected (Fig. 5), in agreement with previous results of 
Frfinken et al. [14]. The main components of the 13,000 band 
are members of the rye ~-amylase/trypsin inhibitor family [16]. 
Sec c 1 displays a high IgE binding capacity, conversely to the 
four major rye c~-amylase inhibitors characterized sofar [16,17]. 
The in vitro IgE binding capacity of BDP was negligible under 
our experimental conditions. 
The allergenic activity of Sec c 1 has also been studied in 
21 patients with high IgE to rye proteins (RAST ->2 to rye). 
This purified protein provoked positive prick tests in 71% of 
patients, with a mean area of papule significantly higher than 
Table 1 
Number of reactive patients (n = 21) and mean area of papule (only 
positive results) produced in prick tests by purified Sec c 1 and BDP 
Positive tests a Papule area (mm 2) 
Sec c l 15 41.7 
BDP 7 15.3 
~'Histamine was used as positive control: 21 positive tests and 17.2 mm 2 
of mean papule area. 
kDa 
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Fig. 5. IgE immunodetection after SDS-PAGE of the following sam- 
ples: 0.5 M NaCI extract (TR) and 0.15 M NaCI extract precipitated 
with (NH4)2SO4 (R) from rye flour; purified proteins Sec c 1 (S), rye 
a-amylase inhibitors-1 to -3 (I~ to I3), rye dimeric a-amylase inhibitor 
RDAI-1 (DI), and the major barley allergen BMAI-1 (BM, positive 
control). Immunodetection was as in Fig. 4, and 10 ~tg of extracts and 
2 ,ug of purified proteins were used. 
histamine (positive control). By contrast, only 33% of patients 
reacted with BDR 
Our results both in vitro and in vivo clearly show that Sec 
c 1 is a major allergen from rye flour. BDP, its barley homo- 
logue, is considerably ess allergenic. Different inhibitory speci- 
ficities among proteins belonging to the cereal inhibitor family 
have been reported previously [16]. 
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